These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 29141075)

  • 1. Treatment for Livedoid Vasculopathy: A Systematic Review.
    Micieli R; Alavi A
    JAMA Dermatol; 2018 Feb; 154(2):193-202. PubMed ID: 29141075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vasculitis and vasculopathy].
    Marković A
    Acta Med Croatica; 2012 Oct; 66 Suppl 1():19-24. PubMed ID: 23193816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of intravenous immunoglobulins in livedoid vasculopathy: long-term follow-up of 11 patients.
    Monshi B; Posch C; Vujic I; Sesti A; Sobotka S; Rappersberger K
    J Am Acad Dermatol; 2014 Oct; 71(4):738-44. PubMed ID: 25022849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous immunoglobulin in resistant livedoid vasculopathy: Analysis of a case series.
    Ozden MG; Ozdemir H; Şenturk N
    Dermatol Ther; 2020 Mar; 33(2):e13229. PubMed ID: 31965687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Livedoid vasculopathy successfully treated with hyperbaric oxygen.
    Banham ND
    Diving Hyperb Med; 2013 Mar; 43(1):35-6. PubMed ID: 23508660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Livedoid vasculopathy - a thrombotic disease.
    Kerk N; Goerge T
    Vasa; 2013 Sep; 42(5):317-22. PubMed ID: 23989066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intractable livedoid vasculopathy successfully treated with hyperbaric oxygen.
    Yang CH; Ho HC; Chan YS; Liou LB; Hong HS; Yang LC
    Br J Dermatol; 2003 Sep; 149(3):647-52. PubMed ID: 14511004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous immunoglobulins in difficult-to-treat ulcerated livedoid vasculopathy: five cases and a literature review.
    Bounfour T; Bouaziz JD; Bézier M; Petit A; Viguier M; Rybojad M; Bagot M
    Int J Dermatol; 2013 Sep; 52(9):1135-9. PubMed ID: 23488633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Livedoid vasculopathy with underlying subcutaneous necrotizing venulitis in an asymptomatic hepatitis B virus carrier: is livedoid vasculopathy a true nonvasculitic disorder?
    Ishibashi M; Miyamoto J; Nagasaka T; Chen KR
    Am J Dermatopathol; 2009 May; 31(3):293-6. PubMed ID: 19384073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Livedoid vasculopathy: long-term follow-up results following hyperbaric oxygen therapy.
    Juan WH; Chan YS; Lee JC; Yang LC; Hong HS; Yang CH
    Br J Dermatol; 2006 Feb; 154(2):251-5. PubMed ID: 16433793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Livedoid Vasculopathy: A French Observational Study Including Therapeutic Options.
    Gardette E; Moguelet P; Bouaziz JD; Lipsker D; Dereure O; Le Pelletier F; Lok C; Maisonobe T; Bessis D; Conard J; Francès C; Barete S
    Acta Derm Venereol; 2018 Oct; 98(9):842-847. PubMed ID: 29738044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management of livedoid vasculopathy focused on direct oral anticoagulants (DOACs): four case reports successfully treated with rivaroxaban.
    Franco Marques G; Criado PR; Alves Batista Morita TC; Cajas García MS
    Int J Dermatol; 2018 Jun; 57(6):732-741. PubMed ID: 29663354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Livedoid vasculopathy: an in-depth analysis using a modified Delphi approach.
    Alavi A; Hafner J; Dutz JP; Mayer D; Sibbald RG; Criado PR; Senet P; Callen JP; Phillips TJ; Romanelli M; Kirsner RS
    J Am Acad Dermatol; 2013 Dec; 69(6):1033-1042.e1. PubMed ID: 24028907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Livedoid vasculopathy - current aspects of diagnosis and treatment of cutaneous infarction.
    Kerk N; Goerge T
    J Dtsch Dermatol Ges; 2013 May; 11(5):407-10. PubMed ID: 23437985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Widespread livedoid vasculopathy.
    Marzano AV; Vanotti M; Alessi E
    Acta Derm Venereol; 2003; 83(6):457-60. PubMed ID: 14690343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Livedoid vasculopathy and its association with factor V Leiden mutation.
    Yong AA; Tan AW; Giam YC; Tang MB
    Singapore Med J; 2012 Dec; 53(12):e258-60. PubMed ID: 23268168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Livedoid Vasculopathy Presenting in a Patient With Sickle Cell Disease.
    Reagin H; Marks E; Weis S; Susa J
    Am J Dermatopathol; 2018 Sep; 40(9):682-685. PubMed ID: 29533274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Case of livedoid vasculopathy with peripheral neuropathy successfully treated with low-dose warfarin.
    Osada S; Kimura Y; Kawana S
    J Dermatol; 2010 Jan; 37(1):98-101. PubMed ID: 20175830
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulsed intravenous immunoglobulin therapy in refractory ulcerated livedoid vasculopathy: seven cases and a literature review.
    Kim EJ; Yoon SY; Park HS; Yoon HS; Cho S
    Dermatol Ther; 2015; 28(5):287-90. PubMed ID: 25845419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ulcerations caused by livedoid vasculopathy associated with a prothrombotic state: Response to warfarin.
    Davis MD; Wysokinski WE
    J Am Acad Dermatol; 2008 Mar; 58(3):512-5. PubMed ID: 18280355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.